Product Details
Co-Aprovel 300/12.5 mg Tablet##
Irbesartan; Hydrochlorothiazide300 mg; 12.5 mg
Tablet
ROA
Oral
Applicant Name
Sanofi-Aventis Nigeria Limited
NRN
A4-8166
Status
Active
Composition
Each tablet contains: Irbesartan 300 mg and Hydrochlorothiazide 12.5 mg Excipients q.s.
ATC Code
C09DA04
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
2 x 14's (in PVC-Alu blisters)
Product Description
Tablet Peach, biconvex, oval-shaped, with a heart debossed on one side and the number "2775" engraved on the other side 27 RNW-PP-296725 CO-APROVEL 300/12.5 MG TABLET IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.5MG IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.5MG A4-8166 Drugs Imported Products 2X14 POM 1 11/29/2022 SANOFI-AVENTIS NIGERIA LIMITED, JAPAUL HOUSE, DR.NURUDEEN OLOWOPOPO AVENUE IKEJA LAGOS 08174600446; 012710135 hilda.nwabudike@sanofi.com SANOFI WINTHROP INDUSTRIE, , 1 RUE DE LA VIERGE, AMBARES ET LAGRAVE, 33565 CARBON-BLANC-CEDEX, FRANCE, France
Manufacturer Name
Sanofi Winthrop Industrie
Manufacturer Country
FRANCE
Approval Date
2023-05-25
Expiry Date
2028-05-24